Tolerogenic Therapies in Cardiac Transplantation
International Journal of Molecular Sciences · 23.04.2025 · 26 (9) · 3968
DOI: 10.3390/ijms26093968 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2025. Verfasst von Laurenz Wolner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Heart Transplantation, Graft Rejection, Transplantation Tolerance, Immune Tolerance. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Heart transplantation remains the gold-standard treatment for end-stage heart failure, yet long-term graft survival is hindered by chronic rejection and the morbidity and mortality caused by lifelong immunosuppression. While advances in medical and device-based therapies have reduced the overall need for transplantation, patients who ultimately require a transplant often present with more advanced disease and comorbidities. Recent advances in tolerance-inducing strategies offer promising avenues to improve allograft acceptance, while minimizing immunosuppressive toxicity. This review explores novel approaches aiming to achieve long-term immunological tolerance, including co-stimulation blockade, mixed chimerism, regulatory T-cell (Treg) therapies, thymic transplantation, and double-organ transplantation. These strategies seek to promote donor-specific unresponsiveness and mitigate chronic rejection. Additionally, expanding the donor pool remains a critical challenge in addressing organ shortages. Innovations such as ABO-incompatible heart transplantation are revolutionizing the field by increasing donor availability and accessibility. In this article, we discuss the mechanistic basis, clinical advancements, and challenges of these approaches, highlighting their potential to transform the future of heart transplantation with emphasis on clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Cardiac and Thoracic Aortic Surgery, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Laurenz Wolner, Bruno K Podesser, Nina Pilat
Zitieren
APA
Wolner, L., William-Olsson, J., Podesser, B. K., Zuckermann, A., & Pilat, N. (2025). Tolerogenic Therapies in Cardiac Transplantation. International Journal of Molecular Sciences, 26(9), 3968. https://doi.org/10.3390/ijms26093968
Vancouver
Wolner L, William-Olsson J, Podesser BK, Zuckermann A, Pilat N. Tolerogenic Therapies in Cardiac Transplantation. International Journal of Molecular Sciences. 2025;26(9):3968. doi:10.3390/ijms26093968
BibTeX
@article{Wolner2025,
author = {Wolner, Laurenz and William-Olsson, Johan and Podesser, Bruno K and Zuckermann, Andreas and Pilat, Nina},
title = {Tolerogenic Therapies in Cardiac Transplantation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {3968},
doi = {10.3390/ijms26093968}
}
EUVIMED